FMLA (Full Microbiology Lab Automation)

Twitter
 

Microbiology laboratories are faced with considerable challenges: a lack of qualified technicians, increasing pressure to deliver more rapid results, and a steady increase in the volume of work.
One of the key aims in our strategy is to provide microbiology labs with fully automated solutions to meet these challenges. Automation makes it possible to improve the care given to patients and enables significant gains in productivity.

 
Automation = standardization

Consistent, high-quality results are critical to a laboratory’s performance, yet the repetition of tasks may be a source of inconsistent results. Automation reduces the risk of misplaced samples, loss of data and interpretation errors.
 
Automation = speed

Full automation is essential to streamline laboratory workflows and to ensure more rapid and standardized results. System integration improves efficiency, increases production and reduces time to results.
 
Automation = controlling healthcare costs
Automation offsets the increasing lack of specialized personnel and thus contributes to the control of healthcare expenditures.
 
Automation = added value
When they are freed from performing tedious and repetitive tasks, biologists and technicians can turn their attention to implementing new technologies. They can also concentrate on high value-added tasks, such as interpreting results to be able to rapidly provide physicians with the crucial information they need to make an accurate diagnosis and prescribe treatment more quickly.

Our automated solutions

  • Inoculation of Petri dishes: PREVI Isola™

  • Automated staining of sample slides: PREVI™ Color Gram

  • Urinary screening (detection of bacteria and particles): UF-1000i 

  • Blood culture: BacT/ALERT®

  • Identification of bacteria and automated antibiogram: VITEK® 2

  • Genotyping of microbial strains: DiversiLab™

  • VIDAS®

  • NucliSENS EasyQ®

  • NucliSENS® easyMAG®

     

A strategic partnership with Hitachi High-Technologies Corporation focused on microbiology and molecular diagnostics
This partnership aims to develop new microbiology and molecular diagnostic systems, leveraging our expertise in biology and Hitachi High-Technologies Corporation’s remarkable engineering capabilities. The new instruments developed under this partnership will be manufactured by Hitachi High-Technologies Corporation and distributed through bioMérieux’s worldwide commercial network.